IPO Guru
Speciality Medicines Logo

Speciality Medicines SME IPO Details

SME Closed

Speciality Medicines SME IPO will open for subscription from 10 April 2026 to 15 April 2026. The company was incorporated in 2012 and operates in the pharmaceutical sector, focusing on trading and distribution of speciality and critical care medicines. It follows a distribution-driven business model, supplying products to hospitals and healthcare institutions. The company has a strong presence across major cities in India, catering to growing demand for specialised healthcare solutions.

Open 20 Mar 2026
Close 24 Mar 2026
Allotment 25 Mar 2026
Listing 30 Mar 2026

IPO Review

100 Strong Apply 1 review
Check Reviews

IPO GMP

₹ 0 (--)
Check GMP

Subscription

2.19 Times
View Sub

Stock Price

As the IPO is listed, here is the Live Share Price for Speciality Medicines

Loading market data...

IPO Summary

IPO Dates 20 to 24 Mar, 2026
Price Band ₹117 to ₹124
Face Value ₹10
Lot Size 1000 Shares
Issue Size ₹29 Cr
Sale Type NII Shares Offered
Employee Discount Not less than 49%
Listing On BSE SME
Min Investment ₹ 2,48,000

What is the Speciality Medicines IPO Timetable?

Track the IPO schedule and key events.

Event Date
IPO Open Date 20 Mar, 2026 Fri
IPO Close Date 24 Mar, 2026 Tue
Basis of Allotment 25 Mar, 2026 Wed
Refunds Initiated 27 Mar, 2026 Fri
Credit to Demat 27 Mar, 2026 Fri
Listing Date 30 Mar, 2026 Mon

What is the Speciality Medicines IPO Lot Size?

Bidding in multiples of 1000 shares.

Application Lots Shares Amount
Retail (Min) 2 2000 ₹2,48,000
Retail (Max) 2 2000 ₹2,48,000
HNI (Min) 3 3000 ₹3,72,000

About Speciality Medicines

Speciality Medicines Limited was established with the objective of catering to the growing demand for niche and high-value pharmaceutical products in India. Over the years, the company has built its presence in the healthcare sector by focusing on specialised therapeutic segments such as critical care, oncology, and chronic disease management. Promoted by experienced professionals from the pharmaceutical industry, the company has developed strong relationships with hospitals, healthcare institutions, and distributors across key regions.

The company’s business model revolves around sourcing, marketing, and distribution of speciality drugs, along with a focus on quality and regulatory compliance. It offers a diverse portfolio of branded and generic medicines, targeting both domestic and selected international markets. By leveraging an asset-light approach and an efficient supply chain network, Speciality Medicines Limited aims to scale its operations while maintaining consistent product availability and expanding its reach in the healthcare ecosystem.

Objects of the Issue

Issue Object
Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat
Estimate Amount ₹12.68 Cr.
Issue Object
Product Registration in International Markets and Product Development for sale in international markets
Estimate Amount ₹2.99 Cr.
Issue Object
Funding for Marketing and Promotional Activities
Estimate Amount ₹1.66 Cr.
Issue Object
To Meet Working Capital Requirements
Estimate Amount ₹8.00 Cr.
Issue Object
General Corporate Purposes
Estimate Amount
Issue Object
Total
Estimate Amount ₹25.33 Cr.

Company Financials

Summary of financial performance including revenue, profit, and debt levels will be populated here.

Promoters and Shareholding Details

Promoter holding details will be updated as soon as they are officially announced.

Frequently Asked Questions

What is the GMP of Speciality Medicines?

The current Grey Market Premium (GMP) of Speciality Medicines is ₹ 0.

What is the Speciality Medicines IPO Price Band?

The price band for Speciality Medicines IPO is 124.

When is the Speciality Medicines IPO Allotment?

The allotment date for Speciality Medicines IPO is March 25, 2026.

How to check Speciality Medicines IPO Allotment Status?

You can check the allotment status on the IPO Allotment Status page or on the registrar's website (Skyline Financial Services Pvt.Ltd.).

Registrar

Skyline Financial Services Pvt.Ltd.

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!